Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mulberry leaves + hippophae protein peptide is a combination dietary supplement, most commonly formulated as a solid beverage. Its main components are an aqueous extract of mulberry leaves (Morus alba) and protein peptides derived from Hippophae (sea buckthorn). This product has been studied for its potential effects on weight loss and metabolic health. The mechanism of action is believed to involve modulation of glucose metabolism, anti-inflammatory gene expression, and possibly gut microbiota composition. Mulberry leaf extract contains bioactive compounds such as flavonoids and anthocyanins that may improve blood glucose control and reduce inflammation, while Hippophae protein peptides may contribute additional antioxidant or metabolic benefits[1][2][3]. The product is primarily marketed as a functional food or dietary supplement rather than a pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on mulberry leaves + hippophae protein peptide.